Product image (placeholder)

VIDIA

MONO-VIDITEST anti-TBEV IgG avidity

REF KZ-313-12 · Mono-cassette · 12 tests · IgG antibodies

CE IVDCE IVDDFor in vitro diagnostic use only

Popis

MONO-VIDITEST anti-TBEV IgG avidity - Single-use cassette mono-test intended for semiquantitative detection of specific IgG antibodies against tick-borne encephalitis virus (TBEV) in human serum or plasma and for determination of IgG antibody avidity. The kit is used in the serological diagnosis of infections caused by TBEV (tick-borne encephalitis virus), such as encephalitis or meningoencephalitis. It can also be used for the differential diagnosis of neuroinfections, monitoring antibody response levels after TBEV vaccination, and assessing the protective effect of vaccination. The kit can also be used to distinguish a primary infection from a past infection or a post-vaccination state. After primary infection, the body initially produces predominantly low-avidity IgG antibodies (with low binding strength) to viral antigens. Later, as a result of antigen-driven selection, high-avidity antibodies become predominant. A predominance of low-avidity IgG antibodies (low relative avidity index, RAI) therefore indicates a recent primary infection, whereas individuals with predominantly high-avidity antibodies had the primary infection in the past or have an anamnestic antibody response due to previous TBEV vaccination. The kit is intended for professional use.

Parametry soupravy

REF
KZ-313-12
Pathogen
Tick-borne encephalitis
Detected marker
IgG antibodies
Method
MONO
Format
Mono-cassette
Number of tests
12 tests
Sample type
Serum / Plasma / Cerebrospinal fluid (CSF)
Evaluation
Qualitative, Semiquantitative
Testing option
Avidity
Incubation
30 min (37°) (+15 min) / 30 min (37°) / 15 min (RT)
Product line
MONO-VIDITEST

Obsah soupravy

  • MONO-VIDITEST cassettes
  • UREA solution
  • STOP solution
  • Instructions for use
  • Quality control certificate